BioCentury
ARTICLE | Company News

Immuno-Designed, Jenner cancer deal

April 9, 2003 7:00 AM UTC

Cellular immunotherapy and cancer company Immuno-Designed Molecules (Paris, France) acquired certain cancer-related assets from Jenner Biotherapies (Walworth, Wis.) in exchange for shares. The deal in...